These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4996773)

  • 21. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 22. [Research on the passage of isohemagglutinins into milk in hemolytic disease of the newborn].
    Lange MM; Fiandino G
    Minerva Pediatr; 1967 Sep; 19(38):1728-34. PubMed ID: 4976636
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of rhesus haemolytic disease in Finland.
    Eklund J
    Haematologia (Budap); 1982 Dec; 15(4):423-6. PubMed ID: 6821166
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-D isoimmunization: cases at the L. Mangiagalli Obstetrical and Gynecological Clinic I from June 1974 to December 1978. Perinatal results].
    Brambati B; Zuliani G; Regalia AL; Pardi G; Chierichetti G; Dambrosio F; Caccamo ML
    Ann Ostet Ginecol Med Perinat; 1980; 101(4):225-34. PubMed ID: 6787970
    [No Abstract]   [Full Text] [Related]  

  • 25. Rh immunoglobulin in prevention of hemolytic disease of newborn child.
    Gorman JG
    N Y State J Med; 1983 Jan; 83(1):42-9. PubMed ID: 6402737
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immune-prevention of fetal erythroblastosis].
    Schubert W
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):540-5. PubMed ID: 4998879
    [No Abstract]   [Full Text] [Related]  

  • 27. [Attempt at Rhesus-prevention at the end of pregnancy].
    Baumgarten K; Reinold E; Koller A
    Wien Med Wochenschr; 1972 Sep; 122(39):551-2. PubMed ID: 4631515
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prenatal immunological research on hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):563-5. PubMed ID: 6788016
    [No Abstract]   [Full Text] [Related]  

  • 29. [Repeated intrauterine fetal death in a woman with genotype Rh-D-/-D-].
    De Virgiliis G; Moroni GA; Margstakler E; Rizzi G; Ferrari G; Remotti G
    Ann Ostet Ginecol Med Perinat; 1978; 99(5):304-7. PubMed ID: 106758
    [No Abstract]   [Full Text] [Related]  

  • 30. The prevention of Rh-haemolytic disease.
    Clarke CA
    Sci Basis Med Annu Rev; 1968; ():168-85. PubMed ID: 4970016
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interruption of pregnancy in hemolytic disease of newborn? Basis for the calculation of homozygosis and heterozygosis in the most important D-positive RH-types].
    Dahr P; Merkl H
    Med Welt; 1967 Sep; 37():2174-6. PubMed ID: 4976302
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the prevention of Rh immunization in Sweden].
    Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA
    Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemolytic Rh disease in Vizcay (current preventive possibilities)].
    Goti JL
    Rev Clin Esp; 1968 Apr; 109(1):37-46. PubMed ID: 4188597
    [No Abstract]   [Full Text] [Related]  

  • 35. [Possibilities of the prevention of hemolytic disease of newborn].
    Berge H
    Z Arztl Fortbild (Jena); 1970 Apr; 64(7):354-7. PubMed ID: 5000584
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-e found in a case of hemolytic disease of the fetus and newborn make use of the IGHV3 superspecies genes.
    Dohmen SE; Muit J; Ligthart PC; Verhagen OJ; van der Schoot CE
    Transfusion; 2008 Jan; 48(1):194-5. PubMed ID: 18184235
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemolytic disease of the newborn due to sensitization to antigen c of Rh system].
    Gatniejewska-Komraus M; Krauze M; Skorczyński M; Sakiel S
    Pediatr Pol; 1974 Jan; 49(1):63-5. PubMed ID: 4204509
    [No Abstract]   [Full Text] [Related]  

  • 38. Current clinical concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemolytic disease of the newborn and therapeutic anti-allergic antibodies].
    Guimbretière J; Dehorne M; Guimbretière L
    Rev Fr Transfus; 1969; 12(1):Suppl:395+. PubMed ID: 4987784
    [No Abstract]   [Full Text] [Related]  

  • 40. [Late results of using plasmapheresis. Prevention of hemolytic disease of the fetus and newborn infant in Rh-compromised pregnancy].
    Timoshenko LV; Timoshenko LI; Minchenko ZhN
    Akush Ginekol (Sofiia); 1986; 25(5):1-8. PubMed ID: 3101532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.